Supersensitive Viral Load Assay in Predicting CD4-Guided Treatment Failure

Table 2.: Median HIV RNA in Copies/ml (Interquartile Range) Between Cases and Controls After HAART Re-Treatment

Time Points	Cases		Controls		P Value^*
Time Points	Median	IQR	Median	IQR	P Value^*
Entry	5	5-17	5	5-10	0.24
1^st HAART re-treatment	15	11-24	5	5-15	0.06
2^nd HAART re-treatment	29	28-30	5	5-10	0.32
Last available HIV RNA < 50 copies/ml	17	8-28	5	5-11	0.004
Last HAART re-treatment at the end of the trial	190	98-470	5	5-11	<0.001

^* We provided p-value from Wilcoxon signed-rank test on values expressed in log10 copies/ml.